(S (NP (NP (NN Thyrotoxicosis)) (PRN (-LRB- -LRB-) (NP (NNP TT)) (-RRB- -RRB-))) (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (DT an) (NN increase)) (PP (IN in) (NP (UCP (DT both) (JJ total) (CC and) (JJ cardiovascu-lar)) (NN mortality))))))) (. .))
(S (NP (NP (CD One)) (PP (IN of) (NP (DT the) (JJ main) (NN thyrotoxicosis) (NNS risks)))) (VP (VBZ is) (NP (NP (JJ Atrial) (NNP Fibrillation)) (PRN (-LRB- -LRB-) (NP (NNP AF)) (-RRB- -RRB-)))) (. .))
(S (NP (RB Right) (NNP AF)) (VP (VBZ predicts) (VP (NN help) (S (NP (JJ medical) (JJ personal)) (VP (NN prescribe) (NP (NP (DT the) (JJ correct) (NNS medicaments)) (CC and) (NP (JJ correct) (ADJP (JJ surgical) (CC or) (JJ radioiodine)) (NN therapy))))))) (. .))
(S (NP (NP (DT The) (JJ main) (NN goal)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBZ is) (VP (VBG creating) (NP (NP (DT a) (NN method)) (PP (IN for) (NP (NP (JJ practical) (NN treatment)) (CC and) (NP (JJ diagnostic) (NNP AF))))))) (. .))
(S (NP (DT This) (NN study)) (VP (VBZ proposes) (NP (NP (DT a) (JJ new) (NN method)) (PP (IN for) (S (VP (VBG assessing) (NP (NP (DT the) (NN risk)) (PP (IN of) (NP (NN occurrence) (JJ atrial) (NN fibrillation))) (PP (IN for) (NP (NP (NNS patients)) (PP (IN with) (NP (NNP TT))))))))))) (. .))
(S (NP (DT This) (NN method)) (VP (VBZ considers) (NP (CC both) (NP (NP (DT the) (NNS features)) (PP (IN of) (NP (DT the) (NN complication)))) (CC and) (NP (NP (DT the) (NNS specifics)) (PP (IN of) (NP (DT the) (JJ chronic) (NN disease)))))) (. .))
(S (NP (DT A) (NN model)) (VP (VBZ is) (VP (VBN created) (PP (VBN based) (PP (IN on) (NP (NP (NN case) (NNS histories)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NN thyrotoxicosis)))))))))) (. .))
(S (NP (PRP We)) (VP (VBD used) (NP (NNP Machine) (NNP Learning) (NNS methods)) (PP (IN for) (S (VP (VBG creating) (NP (JJ several) (NNS models)))))) (. .))
(S (NP (DT Each) (NN model)) (VP (VBZ has) (NP (NNS advantages) (CC and) (NNS disadvantages)) (PP (VBG depending) (PP (IN on) (NP (DT the) (ADJP (JJ diagnostic) (CC and) (JJ medical)) (NNS purposes))))) (. .))
(S (NP (DT The) (VBG resulting) (NNS models)) (VP (VBP show) (NP (NP (JJ high) (NNS results)) (PP (IN in) (NP (NP (DT the) (JJ different) (NNS metrics)) (PP (IN of) (NP (NP (DT the) (NN prediction)) (PP (IN of) (NP (NNP AF))))))))) (. .))
(S (NP (DT These) (NNS models)) (ADJP (ADJP (VBN interpreted)) (CC and) (ADJP (NN simple) (PP (IN for) (NP (NN use))))) (. .))
(S (ADVP (RB Therefore)) (, ,) (NP (NNS models)) (VP (MD can) (VP (VB be) (VP (VBN used) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (NP (DT the) (NN support) (CC and) (NN decision-making) (NN system)) (PRN (-LRB- -LRB-) (NP (NNP DSS)) (-RRB- -RRB-)))))) (PP (IN by) (NP (NP (JJ medical) (NNS specialists)) (PP (IN in) (NP (NP (DT the) (NN treatment) (CC and) (NN diagnostic)) (PP (IN of) (NP (NNP AF)))))))))) (. .))
